These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36250286)

  • 1. Chemically Diverse S. mansoni HDAC8 Inhibitors Reduce Viability in Worm Larval and Adult Stages.
    Noce B; Di Bello E; Zwergel C; Fioravanti R; Valente S; Rotili D; Masotti A; Salik Zeya Ansari M; Trisciuoglio D; Chakrabarti A; Romier C; Robaa D; Sippl W; Jung M; Häberli C; Keiser J; Mai A
    ChemMedChem; 2023 Feb; 18(3):e202200510. PubMed ID: 36250286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic Screening of Histone Deacetylase (HDAC) Inhibitors against Schistosoma mansoni.
    Hassan MM; Sedighi A; Olaoye OO; Häberli C; Merz A; Ramos-Morales E; de Araujo ED; Romier C; Jung M; Keiser J; Gunning PT
    ChemMedChem; 2022 Sep; 17(18):e202100622. PubMed ID: 35983937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel multi-stage histone deacetylase (HDAC) inhibitors that impair Schistosoma mansoni viability and egg production.
    Guidi A; Saccoccia F; Gennari N; Gimmelli R; Nizi E; Lalli C; Paonessa G; Papoff G; Bresciani A; Ruberti G
    Parasit Vectors; 2018 Dec; 11(1):668. PubMed ID: 30587243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of structurally distinct human HDAC6 and HDAC6/HDAC8 inhibitors against S. mansoni larval and adult worm stages.
    Gimmelli R; Papoff G; Saccoccia F; Lalli C; Gemma S; Campiani G; Ruberti G
    PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011992. PubMed ID: 38416775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isophthalic Acid-Based HDAC Inhibitors as Potent Inhibitors of HDAC8 from Schistosoma mansoni.
    Stenzel K; Chakrabarti A; Melesina J; Hansen FK; Lancelot J; Herkenhöhner S; Lungerich B; Marek M; Romier C; Pierce RJ; Sippl W; Jung M; Kurz T
    Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28639720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of Schistosomiasis.
    Heimburg T; Chakrabarti A; Lancelot J; Marek M; Melesina J; Hauser AT; Shaik TB; Duclaud S; Robaa D; Erdmann F; Schmidt M; Romier C; Pierce RJ; Jung M; Sippl W
    J Med Chem; 2016 Mar; 59(6):2423-35. PubMed ID: 26937828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro Testing.
    Simoben CV; Robaa D; Chakrabarti A; Schmidtkunz K; Marek M; Lancelot J; Kannan S; Melesina J; Shaik TB; Pierce RJ; Romier C; Jung M; Sippl W
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29498707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth.
    Chua MJ; Arnold MS; Xu W; Lancelot J; Lamotte S; Späth GF; Prina E; Pierce RJ; Fairlie DP; Skinner-Adams TS; Andrews KT
    Int J Parasitol Drugs Drug Resist; 2017 Apr; 7(1):42-50. PubMed ID: 28107750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Based Design, Synthesis, and Biological Evaluation of Triazole-Based smHDAC8 Inhibitors.
    Kalinin DV; Jana SK; Pfafenrot M; Chakrabarti A; Melesina J; Shaik TB; Lancelot J; Pierce RJ; Sippl W; Romier C; Jung M; Holl R
    ChemMedChem; 2020 Apr; 15(7):571-584. PubMed ID: 31816172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma mansoni.
    Marek M; Kannan S; Hauser AT; Moraes Mourão M; Caby S; Cura V; Stolfa DA; Schmidtkunz K; Lancelot J; Andrade L; Renaud JP; Oliveira G; Sippl W; Jung M; Cavarelli J; Pierce RJ; Romier C
    PLoS Pathog; 2013; 9(9):e1003645. PubMed ID: 24086136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structures of Schistosoma mansoni histone deacetylase 8 reveal a novel binding site for allosteric inhibitors.
    Saccoccia F; Pozzetti L; Gimmelli R; Butini S; Guidi A; Papoff G; Giannaccari M; Brogi S; Scognamiglio V; Gemma S; Ruberti G; Campiani G
    J Biol Chem; 2022 Oct; 298(10):102375. PubMed ID: 35970392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis for the antiparasitic activity of a mercaptoacetamide derivative that inhibits histone deacetylase 8 (HDAC8) from the human pathogen schistosoma mansoni.
    Stolfa DA; Marek M; Lancelot J; Hauser AT; Walter A; Leproult E; Melesina J; Rumpf T; Wurtz JM; Cavarelli J; Sippl W; Pierce RJ; Romier C; Jung M
    J Mol Biol; 2014 Oct; 426(20):3442-53. PubMed ID: 24657767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and Phenotypical Characterization of
    Saccoccia F; Brindisi M; Gimmelli R; Relitti N; Guidi A; Saraswati AP; Cavella C; Brogi S; Chemi G; Butini S; Papoff G; Senger J; Herp D; Jung M; Campiani G; Gemma S; Ruberti G
    ACS Infect Dis; 2020 Jan; 6(1):100-113. PubMed ID: 31661956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, structure-activity relationships, cocrystallization and cellular characterization of novel smHDAC8 inhibitors for the treatment of schistosomiasis.
    Ghazy E; Heimburg T; Lancelot J; Zeyen P; Schmidtkunz K; Truhn A; Darwish S; Simoben CV; Shaik TB; Erdmann F; Schmidt M; Robaa D; Romier C; Jung M; Pierce R; Sippl W
    Eur J Med Chem; 2021 Dec; 225():113745. PubMed ID: 34392190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC8: a multifaceted target for therapeutic interventions.
    Chakrabarti A; Oehme I; Witt O; Oliveira G; Sippl W; Romier C; Pierce RJ; Jung M
    Trends Pharmacol Sci; 2015 Jul; 36(7):481-92. PubMed ID: 26013035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Crystallization Studies, and in vitro Characterization of Cinnamic Acid Derivatives as SmHDAC8 Inhibitors for the Treatment of Schistosomiasis.
    Bayer T; Chakrabarti A; Lancelot J; Shaik TB; Hausmann K; Melesina J; Schmidtkunz K; Marek M; Erdmann F; Schmidt M; Robaa D; Romier C; Pierce RJ; Jung M; Sippl W
    ChemMedChem; 2018 Aug; 13(15):1517-1529. PubMed ID: 29806110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening a repurposing library, the Medicines for Malaria Venture Stasis Box, against Schistosoma mansoni.
    Pasche V; Laleu B; Keiser J
    Parasit Vectors; 2018 May; 11(1):298. PubMed ID: 29764454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Structurally Different HDAC Inhibitors against
    Di Bello E; Noce B; Fioravanti R; Zwergel C; Valente S; Rotili D; Fianco G; Trisciuoglio D; Mourão MM; Sales P; Lamotte S; Prina E; Späth GF; Häberli C; Keiser J; Mai A
    ACS Infect Dis; 2022 Jul; 8(7):1356-1366. PubMed ID: 35732073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibition modulates histone acetylation at gene promoter regions and affects genome-wide gene transcription in Schistosoma mansoni.
    Anderson L; Gomes MR; daSilva LF; Pereira ADSA; Mourão MM; Romier C; Pierce R; Verjovski-Almeida S
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005539. PubMed ID: 28406899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-Scale Overproduction and Purification of Recombinant Histone Deacetylase 8 (HDAC8) from the Human-Pathogenic Flatworm Schistosoma mansoni.
    Marek M; Shaik TB; Duclaud S; Pierce RJ; Romier C
    Methods Mol Biol; 2016; 1436():109-18. PubMed ID: 27246211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.